Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions
Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

NCT05614102

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver, Colorado, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • START | San Antonio San Antonio, Texas, United States
  • Antwerp University Hospital | Oncology Department Antwerp, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00334815

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +15 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Saint Bernards Regional Medical Center Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
View all 61 locations
View Trial Details
Active, Not Recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

NCT05887492

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

NCT05948475

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations
  • UCLA Medical Center Santa Monica, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • The University of Kansas Cancer Center Westwood, Los Angeles, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 87 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details

Related conditions